Hospira Inc., A Pfizer Company Recall: Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5
Hospira Inc., A Pfizer Company Recall: Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Hospira Inc., A Pfizer Company; Product: Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 mL Single-use vial, Rx Only, Sterile, Manufactured by: G
| Recalling firm | Hospira Inc., A Pfizer Company |
|---|---|
| Product | Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 mL Single-use vial, Rx Only, Sterile, Manufactured by: Gland Pharma Limited, Hyderabad, India, Manufactured for: Hospira, Inc, Lake Forest, IL 60045 --- NDC 0409-1140-01 |
| Reason for recall | Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | Nationwide |
| Recall initiated | 20170706 |
| Recall number | D-0980-2017 |
| Category | drug |
| State | IL |
| Country | United States |
$29/mo
Try RecallGuard →